1 recruiting. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
Follow Wu Wenming: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| XH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With Resected Pancreatic Cancer XH001, Ipilimumab Injection, Sintilimab injection - Pancreatic Cancer | Not applicable | Recruiting | Wu Wenming | 28 | 2024-03-12 | 2026-02-13 |
Drug Therapy (1) · Ipilimumab (1) · sintilimab (1)
China (1)